These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 37625781)

  • 61. Charcot-Marie-Tooth type 2 and distal hereditary motor neuropathy: Clinical, neurophysiological and genetic findings from a single-centre experience.
    Luigetti M; Fabrizi GM; Bisogni G; Romano A; Taioli F; Ferrarini M; Bernardo D; Rossini PM; Sabatelli M
    Clin Neurol Neurosurg; 2016 May; 144():67-71. PubMed ID: 26989944
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Intermediate Charcot-Marie-Tooth disease: an electrophysiological reappraisal and systematic review.
    Berciano J; García A; Gallardo E; Peeters K; Pelayo-Negro AL; Álvarez-Paradelo S; Gazulla J; Martínez-Tames M; Infante J; Jordanova A
    J Neurol; 2017 Aug; 264(8):1655-1677. PubMed ID: 28364294
    [TBL] [Abstract][Full Text] [Related]  

  • 63. HDAC6 Inhibitors Rescued the Defective Axonal Mitochondrial Movement in Motor Neurons Derived from the Induced Pluripotent Stem Cells of Peripheral Neuropathy Patients with
    Kim JY; Woo SY; Hong YB; Choi H; Kim J; Choi H; Mook-Jung I; Ha N; Kyung J; Koo SK; Jung SC; Choi BO
    Stem Cells Int; 2016; 2016():9475981. PubMed ID: 28105056
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mutations in C1orf194, encoding a calcium regulator, cause dominant Charcot-Marie-Tooth disease.
    Sun SC; Ma D; Li MY; Zhang RX; Huang C; Huang HJ; Xie YZ; Wang ZJ; Liu J; Cai DC; Liu CX; Yang Q; Bao FX; Gong XL; Li JR; Hui Z; Wei XF; Zhong JM; Zhou WJ; Shang X; Zhang C; Liu XG; Tang BS; Xiong F; Xu XM
    Brain; 2019 Aug; 142(8):2215-2229. PubMed ID: 31199454
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Myelinated axons fail to develop properly in a genetically authentic mouse model of Charcot-Marie-Tooth disease type 2E.
    Lancaster E; Li J; Hanania T; Liem R; Scheideler MA; Scherer SS
    Exp Neurol; 2018 Oct; 308():13-25. PubMed ID: 29940160
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Small heat shock proteins in neurodegenerative diseases.
    Vendredy L; Adriaenssens E; Timmerman V
    Cell Stress Chaperones; 2020 Jul; 25(4):679-699. PubMed ID: 32323160
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Heterogeneity in the properties of NEFL mutants causing Charcot-Marie-Tooth disease results in differential effects on neurofilament assembly and susceptibility to intervention by the chaperone-inducer, celastrol.
    Gentil BJ; Mushynski WE; Durham HD
    Int J Biochem Cell Biol; 2013 Jul; 45(7):1499-508. PubMed ID: 23618875
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Wide phenotypic spectrum in axonal Charcot-Marie-Tooth neuropathy type 2 patients with KIF5A mutations.
    Nam DE; Yoo DH; Choi SS; Choi BO; Chung KW
    Genes Genomics; 2018 Jan; 40(1):77-84. PubMed ID: 29892902
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mutations in MYO9B are associated with Charcot-Marie-Tooth disease type 2 neuropathies and isolated optic atrophy.
    Cipriani S; Guerrero-Valero M; Tozza S; Zhao E; Vollmer V; Beijer D; Danzi M; Rivellini C; Lazarevic D; Pipitone GB; Grosz BR; Lamperti C; Marzoli SB; Carrera P; Devoto M; Pisciotta C; Pareyson D; Kennerson M; Previtali SC; Zuchner S; Scherer SS; Manganelli F; Bähler M; Bolino A
    Eur J Neurol; 2023 Feb; 30(2):511-526. PubMed ID: 36260368
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Update on Charcot-Marie-Tooth disease.
    Patzkó A; Shy ME
    Curr Neurol Neurosci Rep; 2011 Feb; 11(1):78-88. PubMed ID: 21080241
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Small Heat Shock Proteins and Distal Hereditary Neuropathies.
    Nefedova VV; Muranova LK; Sudnitsyna MV; Ryzhavskaya AS; Gusev NB
    Biochemistry (Mosc); 2015 Dec; 80(13):1734-47. PubMed ID: 26878578
    [TBL] [Abstract][Full Text] [Related]  

  • 72. CMT2Q-causing mutation in the Dhtkd1 gene lead to sensory defects, mitochondrial accumulation and altered metabolism in a knock-in mouse model.
    Luan CJ; Guo W; Chen L; Wei XW; He Y; Chen Y; Dang SY; Prior R; Li X; Kuang Y; Wang ZG; Van Den Bosch L; Gu MM
    Acta Neuropathol Commun; 2020 Mar; 8(1):32. PubMed ID: 32169121
    [TBL] [Abstract][Full Text] [Related]  

  • 73. PINK1 and Parkin rescue motor defects and mitochondria dysfunction induced by a patient-derived HSPB3 mutant in Drosophila models.
    Han JE; Kang KH; Kim H; Hong YB; Choi BO; Koh H
    Biochem Biophys Res Commun; 2023 Nov; 682():71-76. PubMed ID: 37804589
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Frequent genes in rare diseases: panel-based next generation sequencing to disclose causal mutations in hereditary neuropathies.
    Dohrn MF; Glöckle N; Mulahasanovic L; Heller C; Mohr J; Bauer C; Riesch E; Becker A; Battke F; Hörtnagel K; Hornemann T; Suriyanarayanan S; Blankenburg M; Schulz JB; Claeys KG; Gess B; Katona I; Ferbert A; Vittore D; Grimm A; Wolking S; Schöls L; Lerche H; Korenke GC; Fischer D; Schrank B; Kotzaeridou U; Kurlemann G; Dräger B; Schirmacher A; Young P; Schlotter-Weigel B; Biskup S
    J Neurochem; 2017 Dec; 143(5):507-522. PubMed ID: 28902413
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease.
    Niemann A; Berger P; Suter U
    Neuromolecular Med; 2006; 8(1-2):217-42. PubMed ID: 16775378
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mitochondrial and axonal abnormalities precede disruption of the neurofilament network in a model of charcot-marie-tooth disease type 2E and are prevented by heat shock proteins in a mutant-specific fashion.
    Tradewell ML; Durham HD; Mushynski WE; Gentil BJ
    J Neuropathol Exp Neurol; 2009 Jun; 68(6):642-52. PubMed ID: 19458545
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Bicyclic-Capped Histone Deacetylase 6 Inhibitors with Improved Activity in a Model of Axonal Charcot-Marie-Tooth Disease.
    Shen S; Benoy V; Bergman JA; Kalin JH; Frojuello M; Vistoli G; Haeck W; Van Den Bosch L; Kozikowski AP
    ACS Chem Neurosci; 2016 Feb; 7(2):240-58. PubMed ID: 26599234
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Charcot-Marie-Tooth disease: an update.
    Shy ME
    Curr Opin Neurol; 2004 Oct; 17(5):579-85. PubMed ID: 15367862
    [TBL] [Abstract][Full Text] [Related]  

  • 79. HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease.
    Benoy V; Van Helleputte L; Prior R; d'Ydewalle C; Haeck W; Geens N; Scheveneels W; Schevenels B; Cader MZ; Talbot K; Kozikowski AP; Vanden Berghe P; Van Damme P; Robberecht W; Van Den Bosch L
    Brain; 2018 Mar; 141(3):673-687. PubMed ID: 29415205
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Distal hereditary motor neuropathy in Korean patients with a small heat shock protein 27 mutation.
    Chung KW; Kim SB; Cho SY; Hwang SJ; Park SW; Kang SH; Kim J; Yoo JH; Choi BO
    Exp Mol Med; 2008 Jun; 40(3):304-12. PubMed ID: 18587268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.